↓ Skip to main content

Phase II trial of ixabepilone, an epothilone B analog, given daily for three days every three weeks, in metastatic breast cancer

Overview of attention for article published in Investigational New Drugs, August 2006
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
40 Dimensions

Readers on

mendeley
9 Mendeley
Title
Phase II trial of ixabepilone, an epothilone B analog, given daily for three days every three weeks, in metastatic breast cancer
Published in
Investigational New Drugs, August 2006
DOI 10.1007/s10637-006-9006-7
Pubmed ID
Authors

Neelima Denduluri, James J. Lee, Janice Walshe, Arlene W. Berman, Ujala Vatas, Catherine K. Chow, Seth M. Steinberg, Michael C. Cox, Jennifer A. Low, Sandra M. Swain

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 11%
Unknown 8 89%

Demographic breakdown

Readers by professional status Count As %
Librarian 1 11%
Other 1 11%
Student > Doctoral Student 1 11%
Student > Bachelor 1 11%
Student > Master 1 11%
Other 2 22%
Unknown 2 22%
Readers by discipline Count As %
Agricultural and Biological Sciences 3 33%
Nursing and Health Professions 2 22%
Biochemistry, Genetics and Molecular Biology 1 11%
Medicine and Dentistry 1 11%
Unknown 2 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 February 2017.
All research outputs
#7,567,797
of 23,081,466 outputs
Outputs from Investigational New Drugs
#328
of 1,175 outputs
Outputs of similar age
#23,258
of 66,978 outputs
Outputs of similar age from Investigational New Drugs
#2
of 5 outputs
Altmetric has tracked 23,081,466 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,175 research outputs from this source. They receive a mean Attention Score of 4.7. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 66,978 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.